Brave Asset Management’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,500
Closed -$243K 155
2022
Q2
$243K Hold
2,500
0.11% 109
2022
Q1
$281K Hold
2,500
0.1% 106
2021
Q4
$337K Sell
2,500
-1,000
-29% -$139K 0.09% 92
2021
Q3
$494K Sell
3,500
-200
-5% -$26.9K 0.14% 69
2021
Q2
$474K Sell
3,700
-350
-9% -$41.2K 0.14% 74
2021
Q1
$518K Buy
4,050
+1,750
+76% +$323K 0.17% 68
2020
Q4
$413K Buy
+2,300
New +$511K 0.16% 75

Other funds holding QDEL

Brave Asset Management's QDEL Position: Q3 2022 in Review

Brave Asset Management sold out of QuidelOrtho (QDEL) in Q3 2022, closing a stake of 2,500 shares — an estimated $243K sold.

Brave Asset Management first reported a position in QDEL in Q4 2020 and held it in 7 quarters. The position peaked at $518K in Q1 2021. 315 funds tracked by Wall St. Rank hold QDEL as of Q3 2022.

  • Brave Asset Management reported no remaining QuidelOrtho position as of Q3 2022 after selling out during the quarter.
  • Brave Asset Management sold 2,500 QuidelOrtho shares in Q3 2022, an estimated $243K.
  • Brave Asset Management first reported a position in QuidelOrtho in Q4 2020 and held it in 7 quarters.
  • Brave Asset Management's QuidelOrtho position peaked at $518K in Q1 2021.
  • 315 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2022.

Based on Brave Asset Management's 13F filing for Q3 2022, filed 13 Oct 2022.